BOS-181

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameBOS-181
Drug Alias NameBOS-181MAK-181
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUDP-3-O-acyl-N-acetylglucosamine deacetylase inhibitors
TargetsUDP-3-O-acyl-N-acetylglucosamine deacetylase
Therapy Area/IndicationsPseudomonas Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharma AgBoston Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsPseudomonas Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A